Nawaf Alotaibi
- Emergency Medical Services top 5%
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes 4
- Health top 10%
- Modeling and Simulation top 10%
- COVID-19 epidemiological studies 3
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 6
-
- Advanced Drug Delivery Systems 5
- Advancements in Transdermal Drug Delivery 3
-
- Computational Drug Discovery Methods 3
-
- Nanoparticle-Based Drug Delivery 3
-
- Synthesis and biological activity 2
- Co-authors
- Md Ali MujtabaDon D. SinVirginia ChenFernando Sergio Leitão FilhoZsuzsanna HollanderMuhammad Wahab AmjadDhfer AlshaybanBander Balkhi
- Journals
- SHILAP Revista de lepidopterología (4 papers)American Journal of Respiratory and Critical Care Medicine (1 paper)Medicine (1 paper)
- Partner nations
- Saudi ArabiaCanadaUnited States
In The Last Decade
Nawaf Alotaibi
52 papers receiving 549 citations
Peers
Comparison fields: 5 of 122
- Emergency Medical Services 75
- Geriatrics and Gerontology 32
- Applied Microbiology and Biotechnology 12
- Health 50
- Modeling and Simulation 21
Countries citing papers authored by Nawaf Alotaibi
This map shows the geographic impact of Nawaf Alotaibi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nawaf Alotaibi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nawaf Alotaibi more than expected).
Fields of papers citing papers by Nawaf Alotaibi
This network shows the impact of papers produced by Nawaf Alotaibi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nawaf Alotaibi. The network helps show where Nawaf Alotaibi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nawaf Alotaibi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 13 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 7 | |
| 8 | Formulation and evaluation of chitosan-based nanogel for oral delivery of diosmin. | 2023 | 2 |
| 9 | 2023 | 9 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 7 | |
| 13 | 2022 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 0 | |
| 16 | 2020 | 6 | |
| 17 | 2019 | 4 | |
| 18 | 2019 | 12 | |
| 19 | Awareness about Oral Cancer among Dental and Medical Practitioners in Riyadh, Saudi Arabia: A Cross-Sectional Study | 2019 | 0 |
| 20 | 2018 | 98 |
About Nawaf Alotaibi
Nawaf Alotaibi is a scholar working on Geriatrics and Gerontology, Family Practice and Pharmaceutical Science, having authored 56 papers that have together received 561 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Advanced Drug Delivery Systems (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers), Computational Drug Discovery Methods (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Advancements in Transdermal Drug Delivery (3 papers), COVID-19 epidemiological studies (3 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Emergency Medical Services (75 citations), Geriatrics and Gerontology (32 citations) and Applied Microbiology and Biotechnology (12 citations). Nawaf Alotaibi has collaborated with scholars based in Saudi Arabia, Canada and United States. Frequent co-authors include Md Ali Mujtaba, Don D. Sin, Virginia Chen, Fernando Sergio Leitão Filho, Zsuzsanna Hollander, Muhammad Wahab Amjad, Dhfer Alshayban, Bander Balkhi, Corey Nislow and Sheena Tam. Their work appears in journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.